Severe Hyperthyroidism and Complete Hydatidiform Mole in Perimenopausal Woman: Case Report and Literature Review

• Published in: Curēus (Palo Alto, CA) Vol. 14; no. 2; p. e22240
• Main Authors: Da Silva Santos, Tiago, Santos Monteiro, Sílvia, Pereira, Maria Teresa, Garrido, Susana, Leal, Manuela, Andrade, Carina, Vilaverde, Joana, Dores, Jorge
• Format: Journal Article
• Language: English
• Published: United States Cureus Inc 15-02-2022; Cureus
• Subjects: Abdomen; Amenorrhea; Anemia; Blood; Case reports; Chemotherapy; Disease; Edema; Endocrinology/Diabetes/Metabolism; Hemoglobin; Hyperthyroidism; Hysterectomy; Internal Medicine; Laboratories; Medical imaging; Obstetrics/Gynecology; Patients; Pregnancy; Suctioning; Thyroid gland; Ultrasonic imaging; Uterus; Vagina; Womens health; beta-human chorionic gonadotropin (β-hcg); hydatidiform mole; hyperthyroidism; perimenopausal; gestational trophoblastic disease
• ISSN: 2168-8184; 2168-8184
• DOI: 10.7759/cureus.22240

Gestational trophoblastic disease (GTD) represents a heterogeneous group of disorders within placental trophoblastic cells that are rather rare in perimenopausal ages. One of its complications is the development of secondary clinical hyperthyroidism, which can be potentially complicated if not properly and early recognized. We report the case of a 50-year-old perimenopausal woman, gravida 2 para 2, who presented to the emergency department with severe acute lower abdominal pain and abnormal uterine bleeding for one month. She also reported abnormal sweating and palpitation for a one-week duration and amenorrhea for the previous three months. Abdominal examination showed a pelvic mass resembling a 15-week sized uterus. Serum β-hCG levels were strongly increased, and abdomen ultrasound displayed an enlarged uterus with "snow-storm" features, compatible with the diagnosis of GTD. Laboratory data revealed suppressed TSH levels and high free thyroxine and free triiodothyronine levels (4 and 1.5 times above the upper limit of normality, respectively). Thyrotropin-receptor antibodies (TRAb) levels were negative, and thyroid ultrasound excluded major structural disease. She was managed with anti-thyroid drugs, Lugol's iodine, beta-blockers, and steroids during preoperative care. Thereafter, she underwent surgery, being diagnosed with a hydatidiform mole postoperatively. Her thyroid function returned to normal after three months, without the further need for antithyroid drugs. This case highlights the importance of considering GTD as an aetiology for thyrotoxicosis in perimenopausal women, especially in the absence of findings suggesting primary thyroid disease.